Peter Bowers

1.8k total citations
19 papers, 1.3k citations indexed

About

Peter Bowers is a scholar working on Hematology, Hepatology and Genetics. According to data from OpenAlex, Peter Bowers has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 7 papers in Hepatology and 4 papers in Genetics. Recurrent topics in Peter Bowers's work include Erythropoietin and Anemia Treatment (13 papers), Hepatitis C virus research (7 papers) and Iron Metabolism and Disorders (5 papers). Peter Bowers is often cited by papers focused on Erythropoietin and Anemia Treatment (13 papers), Hepatitis C virus research (7 papers) and Iron Metabolism and Disorders (5 papers). Peter Bowers collaborates with scholars based in United States, Austria and France. Peter Bowers's co-authors include Douglas T. Dieterich, Mark Sulkowski, Betty L. Goon, David H. Henry, Addison K. May, Timothy C. Fabian, Ronald G. Pearl, Andrew Gettinger, Robert An and Stephen O. Heard and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Peter Bowers

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bowers United States 12 631 538 501 223 221 19 1.3k
J Wilde United Kingdom 18 638 1.0× 296 0.6× 177 0.4× 27 0.1× 237 1.1× 34 1.1k
Joost J. van Veen United Kingdom 19 532 0.8× 100 0.2× 166 0.3× 57 0.3× 131 0.6× 34 1.2k
David Wallace United Kingdom 13 210 0.3× 155 0.3× 165 0.3× 11 0.0× 229 1.0× 34 819
Jeff Morçet France 18 373 0.6× 48 0.1× 162 0.3× 19 0.1× 387 1.8× 35 945
Chantal R. Harrison United States 11 216 0.3× 22 0.0× 157 0.3× 451 2.0× 78 0.4× 26 1.1k
Martin J. Inwood Canada 13 374 0.6× 36 0.1× 91 0.2× 47 0.2× 82 0.4× 33 846
B T Colvin United Kingdom 19 993 1.6× 42 0.1× 117 0.2× 17 0.1× 235 1.1× 63 1.6k
Janet Birchall United Kingdom 11 484 0.8× 29 0.1× 63 0.1× 355 1.6× 123 0.6× 21 916
Hazel Tinegate United Kingdom 12 365 0.6× 25 0.0× 58 0.1× 379 1.7× 127 0.6× 18 798
Jody L. Kujovich United States 12 510 0.8× 101 0.2× 110 0.2× 10 0.0× 104 0.5× 17 949

Countries citing papers authored by Peter Bowers

Since Specialization
Citations

This map shows the geographic impact of Peter Bowers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bowers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bowers more than expected).

Fields of papers citing papers by Peter Bowers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bowers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bowers. The network helps show where Peter Bowers may publish in the future.

Co-authorship network of co-authors of Peter Bowers

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bowers. A scholar is included among the top collaborators of Peter Bowers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bowers. Peter Bowers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Glaspy, John A., Jeffrey Crawford, Johan Vansteenkiste, et al.. (2010). Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. British Journal of Cancer. 102(2). 301–315. 176 indexed citations
2.
Pérgola, Pablo E., Gary Gartenberg, Min Fu, et al.. (2010). A Randomized Controlled Study Comparing Once-Weekly to Every-2-Week and Every-4-Week Dosing of Epoetin Alfa in CKD Patients with Anemia. Clinical Journal of the American Society of Nephrology. 5(4). 598–606. 9 indexed citations
3.
Pérgola, Pablo E., Gary Gartenberg, Min Fu, et al.. (2009). A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia. Clinical Journal of the American Society of Nephrology. 4(11). 1731–1740. 15 indexed citations
4.
Henry, David H., et al.. (2007). Natural History of Anemia Associated with Interferon/Ribavirin Therapy for Patients with HIV/HCV Coinfection. AIDS Research and Human Retroviruses. 23(1). 1–9. 12 indexed citations
5.
Corwin, Howard L., Andrew Gettinger, Timothy C. Fabian, et al.. (2007). Efficacy and Safety of Epoetin Alfa in Critically Ill Patients. New England Journal of Medicine. 357(10). 965–976. 360 indexed citations
6.
Balan, Vijayan, David H. Schwartz, George Y. Wu, et al.. (2005). Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon/Ribavirin. The American Journal of Gastroenterology. 100(2). 299–307. 49 indexed citations
7.
Dicato, M., et al.. (2005). The relationship of body weight and efficacy of fixed dose epoetin alfa vs placebo. Journal of Clinical Oncology. 23(16_suppl). 8192–8192. 4 indexed citations
8.
Vercammen, Els, et al.. (2005). Analysis of the effect of body weight on the efficacy and safety of epoetin alfa. Journal of Clinical Oncology. 23(16_suppl). 8184–8184. 1 indexed citations
9.
Pockros, Paul J., Mitchell L. Shiffman, Eugene R. Schiff, et al.. (2004). Epoetin Alfa Improves Quality of Life in Anemic Hcv–Infected Patients Receiving Combination Therapy. Hepatology. 40(6). 1450–1458. 116 indexed citations
10.
Saag, Michael S., Peter Bowers, G Leitz, & Alexandra M. Levine. (2004). Once-Weekly Epoetin Alfa Improves Quality of Life and Increases Hemoglobin in Anemic HIV + Patients. AIDS Research and Human Retroviruses. 20(10). 1037–1045. 18 indexed citations
11.
Henry, David H., et al.. (2004). Epoetin Alfa. Archives of Internal Medicine. 164(3). 262–262. 78 indexed citations
12.
Afdhal, Nezam H., Douglas T. Dieterich, Paul J. Pockros, et al.. (2004). Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study1 1The other PROACTIVE Study Group investigators included the following: Vijayan Balan, M.D., Mayo Clinic Scottsdale, Scottsdale, Arizona; Norbert Bräu, M.D., Bronx VA Medical Center, Bronx, New York; Robert Brown, M.D., M.P.H., NY Presbyterian Medical Center, New York, New York; William Carey, M.D., Cleveland Clinic Foundation, Cleveland, Ohio; Andrea Duchini, M.D., Baylor College of Medicine, Houston, Texas; Greg Everson, M.D., University of Colorado Health Sciences Center, Denver, Colorado; Michael Fried, M.D., University of North Carolina, Chapel Hill, North Carolina; Robert Gish, M.D., California Pacific Medical Center, San Francisco, California; Ira Jacobson, M.D., Weill Medical College of Cornell University, New York, New York; John W. King, LSU Health Sciences Center, Shreveport, LA; Raymond Koff, M.D., University of Massachusetts Memorial Health Care, Worcester, Massachusetts; William Lee, M.D., University of Texas Southwestern Medical Center, Dallas, Texas; Mark A. Levstik, M.D., The University of Tennessee, Memphis, Tennessee; John G. McHutchison, M.D., Scripps Clinic, La Jolla, California; Marion Peters, M.D., University of California San Francisco, San Francisco, California; Kenneth Sherman, M.D., Ph.D., University of Cincinnati College of Medicine, Cincinnati, Ohio; Coleman Smith, M.D., Minnesota Clinical Research Center, St. Paul, MN; Ronald Wasserman, M.D., Hepatitis Resource Center, Walnut Creek, California.. Gastroenterology. 126(5). 1302–1311. 232 indexed citations
13.
Dieterich, Douglas T., Norbert Bräu, Tarek Hassanein, et al.. (2003). Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa. The American Journal of Gastroenterology. 98(11). 2491–2499. 164 indexed citations
14.
Goon, Betty L., et al.. (2003). Once-Weekly Epoetin Alfa Dosing Is as Effective as Three Times–Weekly Dosing in Increasing Hemoglobin Levels and Is Associated With Improved Quality of Life in Anemic HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(4). 368–378. 24 indexed citations
15.
Balan, Vijayan, George Y. Wu, Andrew J. Muir, Emmet B. Keeffe, & Peter Bowers. (2003). Erythropoietic response to anemia is decreased in patients infected with hepatitis C virus (HCV) receiving combination ribavirin and pegylated interferon (RBV/PEG-IFN) therapy. Gastroenterology. 124(4). A751–A751. 3 indexed citations
16.
17.
Bowers, Peter. (1993). Selections from Current Literature: Psychiatric Disorders in Primary Care. Family Practice. 10(2). 231–237. 8 indexed citations
18.
19.
Bowers, Peter. (1990). Selections from Current Literature: Mammographic Breast Cancer Screening. Family Practice. 7(4). 333–338.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Wilde Breakdown of academic impact, for papers by Joost J. van Veen Breakdown of academic impact, for papers by David Wallace Breakdown of academic impact, for papers by Jeff Morçet Breakdown of academic impact, for papers by Chantal R. Harrison Breakdown of academic impact, for papers by Martin J. Inwood Breakdown of academic impact, for papers by B T Colvin Breakdown of academic impact, for papers by Janet Birchall Breakdown of academic impact, for papers by Hazel Tinegate Breakdown of academic impact, for papers by Jody L. Kujovich
Rankless by CCL
2026